Navigation Links
'Prozac miracle' could end in disaster

A major lawsuit has been launched against the British pharmaceutical giant GlaxoSmithKline on behalf of a group of people who say they became chronically addicted to an antidepressant drug in the same class as Prozac. The case, which has been filed in California, is the first ever to claim damages for addiction against one of the drug companies that have made billions from SSRIs (selective serotonin reuptake inhibitors) - the class of drug of which Prozac is the best known - and which were hailed as "wonderdrugs" when they first hit the market in the 1980s.

// The drug is known as Seroxat in Britain and Paxil in the US. This drug has the generic name-Paroxetine. There are 35 people in the class action at the moment - from a website designer to a bank fraud investigator and a senior airforce officer - but many more are expected to join it. All were prescribed Paxil/Seroxat for mild depression or anxiety and none was told they might become hooked. When they tried to stop taking it, they suffered violent and disturbing symptoms, including jolting pains in the head, vertigo, loss of coordination, abdominal discomfort, flu symptoms, agitation and confusion.

The lawsuit alleges that the manufacturer, GlaxoSmithKline, has deliberately failed to warn doctors and patients that Paxil/Seroxat can cause severe withdrawal reactions. The US lawyers allege that all the SSRI class of antidepressants have the potential to cause withdrawal reactions when people try to stop taking them, but that Paxil/Seroxat is the worst.


'"/>




Page: 1

Related medicine news :

1. Maharashtra warns against Mahims miracle water
2. Virus Level could Predict Cervical Cancer Risk
3. Beware of the oral patch! It could be cancer!!!
4. Wonder drug - could end in disaster
5. Pollution could be a risk
6. Fright could be more harmful
7. Pregnant smokers could harm their child
8. Snoring could be a warning
9. Anthrax drug doxycycline could stunt fetal growth
10. Hike in drug licence fee could hit several SSI units in TN
11. Lengthy Fingers could predict heart attacks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook a hot ... suggests that Americans prefer their dogs straight off the grill. Of the 90 percent ... favorite way to cook a hot dog, far outpacing other cooking methods such as ...
(Date:5/26/2016)... ... , ... Connor Sports, through its Connor Cares initiative, will continue ... Catchings Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and ... forms and levels of the game, Connor Sports has committed to a significantly increased ...
(Date:5/26/2016)... ... ... MadgeTech will be showcasing its line of data logging products , ... MadgeTech headquarters. With products sold in more than 100 countries around the world, MadgeTech ... , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech data loggers around ...
(Date:5/26/2016)... ... May 26, 2016 , ... Memorial Day Weekend marks the ... Insurance is sharing tips to make sure your family and vehicle are ready ... Safety Council, there may be 439 deaths and an additional 50,500 serious injuries from ...
(Date:5/26/2016)... Rafael, CA (PRWEB) , ... May 26, 2016 ... ... will be offering campers a multitude of activities from daily practices, arts & ... self-confidence. , Camp Directors Amber East-D’Anna and Christy Evans have combined backgrounds in ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 MedDay, a biotechnology ... that an oral presentation entitled "High doses of biotin in ... will be given by Professor Ayman Tourbah , Principal ... of the European Academy of Neurology (EAN) in ... disorders 3" will take place on Sunday, 29 May 2016 ...
(Date:5/24/2016)... 24, 2016   ... primären Endpunkte und demonstriert Ebenbürtigkeit bei ... ‚ausgezeichneter plus guter , ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) ... positive Daten von der MORA-Studie der Phase III ...
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
Breaking Medicine Technology: